Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors
EPIC: ALNY
Market: NASDAQ
52-week High/Low: $138.73 / $52.37
Sector: Pharmaceuticals
Market Cap: $5,437.37M
Website: www.alnylam.com
Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing therapeutics based on ribonucleic acid interface (RNAi). The RNAi therapeutic program, ALN-RSV01, is in Phase II clinical trials for the treatment of human respiratory syncytial virus (RSV), infection.

Alnylam Pharmaceuticals

www.alnylam.com

Interactive graph

col 3
col 4
col 5
col 6

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.